133 related articles for article (PubMed ID: 636903)
1. Effect of lithium on hypothalamic-pituitary dopaminergic function.
Lal S; Nair NP; Guyda H
Acta Psychiatr Scand; 1978 Jan; 57(1):91-6. PubMed ID: 636903
[TBL] [Abstract][Full Text] [Related]
2. Antagonizing effect of lithium on the development of dopamine supersensitivity in the tuberoinfundibular system.
Tanimoto K; Maeda K; Chihara K
Brain Res; 1982 Aug; 245(1):163-6. PubMed ID: 6811103
[TBL] [Abstract][Full Text] [Related]
3. Effect of naloxone or levallorphan on serum prolactin concentrations and apomorphine-induced growth hormone secretion.
Lal S; Nair NP; Cervantes P; Pulman J; Guyda H
Acta Psychiatr Scand; 1979 Feb; 59(2):173-9. PubMed ID: 420037
[TBL] [Abstract][Full Text] [Related]
4. Effect of clozapine on apomorphine-induced growth hormone secretion and serum prolactin concentrations in schizophrenia.
Nair NP; Lal S; Cervantes P; Yassa R; Guyda H
Neuropsychobiology; 1979; 5(3):136-42. PubMed ID: 431802
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by lithium of dopamine receptors in rat prolactin release.
Tanimoto K; Maeda K; Chihara K
Brain Res; 1981 Nov; 223(2):335-42. PubMed ID: 6269703
[TBL] [Abstract][Full Text] [Related]
6. Effect of some peptides on dopaminergic function in man.
Lal S; Nair NP; Isaac I; Thavundayil J; Guyda H
J Neural Transm Suppl; 1990; 29():173-81. PubMed ID: 2113567
[TBL] [Abstract][Full Text] [Related]
7. CCK-33 antagonizes apomorphine-induced growth hormone secretion and increases basal prolactin levels in man.
Nair NP; Lal S; Thavundayil JX; Wood PL; Etienne P; Guyda H
Neuropeptides; 1984 Jun; 4(4):281-91. PubMed ID: 6472582
[TBL] [Abstract][Full Text] [Related]
8. Effect of choline on central dopaminergic function in normal subjects.
Lal S; Etienne P; Thavundayil J; Nair NP; Collier B; Rastogi R; Guyda H; Schwartz G
J Neural Transm; 1981; 50(1):29-37. PubMed ID: 7205247
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced growth hormone and prolactin responses in schizophrenia research.
Lal S; Nair NP; Iskandar HI; Thavundayil JX; Etienne P; Wood PL; Guyda H
Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):631-7. PubMed ID: 6131495
[TBL] [Abstract][Full Text] [Related]
10. Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy.
Ettigi P; Nair NP; Lal S; Cervantes P; Guyda H
J Neurol Neurosurg Psychiatry; 1976 Sep; 39(9):870-6. PubMed ID: 993808
[TBL] [Abstract][Full Text] [Related]
11. Lithium effects on haloperidol-induced pre- and postsynaptic dopamine receptor supersensitivity.
Verimer T; Goodale DB; Long JP; Flynn JR
J Pharm Pharmacol; 1980 Sep; 32(9):665-6. PubMed ID: 6107377
[No Abstract] [Full Text] [Related]
12. Genotypic influences on pituitary responsiveness to haloperidol in mice.
Morgan DG; Randall JS; Telford NA; Gordon MN; Sinha YN; Finch CE; Randall PK
Psychoneuroendocrinology; 1987; 12(3):211-8. PubMed ID: 3615750
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic stimulation of prolactin release.
Denef C; Manet D; Dewals R
Nature; 1980 May; 285(5762):243-6. PubMed ID: 6154895
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity.
Pert A; Rosenblatt JE; Sivit C; Pert CB; Bunney WE
Science; 1978 Jul; 201(4351):171-3. PubMed ID: 566468
[TBL] [Abstract][Full Text] [Related]
15. Hormones, dopamine receptors and schizophrenia.
Meltzer HY; Busch D; Fang VS
Psychoneuroendocrinology; 1981; 6(1):17-36. PubMed ID: 7244055
[No Abstract] [Full Text] [Related]
16. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
Pittman KJ; Jakubovic A; Fibiger HC
Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
[TBL] [Abstract][Full Text] [Related]
17. Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in the control of prolactin, growth hormone and gonadotropin secretion in prepubertal rats.
González LC; Pinilla L; Tena-Sempere M; Aguilar E
J Endocrinol; 1999 Sep; 162(3):417-24. PubMed ID: 10467233
[TBL] [Abstract][Full Text] [Related]
18. Prolactin responses to haloperidol in drug-free and treated schizophrenic patients.
Markianos M; Sakellariou G; Bistolaki E
J Neural Transm Gen Sect; 1991; 83(1-2):37-42. PubMed ID: 2018629
[TBL] [Abstract][Full Text] [Related]
19. Modulating role of lithium on dopamine turnover, prolactin release, and behavioral supersensitivity following haloperidol and reserpine.
McIntyre IM; Kuhn C; Demitriou S; Fucek FR; Stanley M
Psychopharmacology (Berl); 1983; 81(2):150-4. PubMed ID: 6415746
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of lithium on central dopamine and serotonin activity reflected by inhibition of prolactin and growth hormone secretion in the rat.
Smythe GA; Brandstater JF; Lazarus L
Aust J Biol Sci; 1979 Jun; 32(3):329-34. PubMed ID: 508205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
